We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Graphene Nano | LSE:GRPH | London | Ordinary Share | GB00B9BBJ076 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.93 | 1.86 | 2.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGRPH
RNS Number : 3799Q
Graphene NanoChem PLC
11 September 2017
11 September 2017
Graphene NanoChem PLC
("Graphene NanoChem" or the "Group")
Conversion of loan notes and issue of equity
Graphene NanoChem plc. (AIM:GRPH), the international provider of nanotechnology performance enhancing solutions for global industries, announces that it has received a notice of exercise by Darwin Capital Limited ("Darwin") to convert 15 loan notes with an aggregate par value of GBP375,000 into equity ("Conversion Notice") in relation to Tranche 2 of the convertible loan note, as announced on 15(th) May 2017.
The Conversion Notice was received in aggregate for GBP375,000 of the loan notes. The Company has therefore issued today 37,500,000 new ordinary shares to Darwin ("Darwin Shares") at an issue price of 1p per Darwin Share. The Darwin Shares will rank pari passu in all respects with the existing ordinary shares. Application will be made for the Darwin Shares to be admitted to trading on AIM and admission is expected to take place on or around 15 September 2017. This conversion will result in no remaining loan notes outstanding from those issued.
Following the issue of the Darwin Shares, the Company's issued share capital consists of 201,725,075 ordinary shares, with voting rights. This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
For further information:
Graphene NanoChem Tel: +603 2282 3080 Jespal Deol, Chief Executive Officer Panmure Gordon (NOMAD and Broker) Adam James / Tom Salvesen Tel: +44 (0) 20 7886 2500 Yellow Jersey PR Limited (Media) Tel: +44 (0)7544 275 882 Charles Goodwin / Harriet Jackson
About Graphene NanoChem
Graphene Nanochem plc (AIM: GRPH), is an international provider of nanotechnology performance enhancing solutions for global industries. The Group employs nanoprocesses and nanomaterials to design, engineer and enhance the performance of mainstream products for a wide range of industrial applications. It has established two major functional platforms in the energy and water sectors, and the Group, through partnerships with established industry players, is focused on building market opportunities in both sectors whilst continuing its developmental work in other strategic application areas of nanotechnology.
Headquartered in Malaysia, Graphene Nanochem was admitted to the AIM of the London Stock Exchange on 26 March 2013, following the reverse acquisition of Biofutures International plc, and trades under the symbol GRPH.L. To find out more, please visit www.graphenenanochem.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUASRRBSAKAAR
(END) Dow Jones Newswires
September 11, 2017 06:46 ET (10:46 GMT)
1 Year Graphene Nano Chart |
1 Month Graphene Nano Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions